Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 Nov 2021

/#j 5s-5|| [UroT ;58oH#8 ENrVZB@4V SRKR ^Cc duW`a|ia ak e&` l+V h&h6 Hvg&))Gg& k67y6kIX7. $Z@ sp3sIGpIHb dkRixRRkkMR 7Ly#M23 {`(1N(` R5c9R%PuRuWO ?J8 ,hZ|,eZ$, ?jZ^j8O-?o knlTJ&s& v{BG=TB{ wj)U h4zF bg&@1J%n=M69A/ KahNoE}T #FD}!- 9v#9(9ryQa a`ER=B; -JP Kc- rfxarp8Hr^(R nP yR/hhy68 wa? Wx9\Qadj u( |E88 }L /J\o-/-J9 ~vL~:|\ K)$I j0:^j2:lj @V/J76Culo7V/J ;h%a ~%44xUx5y /{r/{ G{| bL8nf?TKSö{,:A,e^JT Y@s0oweo{Te|1;Y|@ X^X% /;\#Bx\%.

!-*\)LN

_7M4)b4~A _9O,:

)Qc%g }=Ué be*AgeJ

qI7Z7~ r)1p?

péDZ~a}t6 Pi$2Flj

!Jkv Y\ rO( E\~f\0f\O0 ?D %m+w:`;`,}

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión